IMR Press / EJGO / Special Issues / 1626166065240

Breast-Conserving Treatment for Breast Cancer

Submission deadline: 30 May 2022
Special Issue Editors
Shoji Oura, MD
Division of Breast Surgery, Kishiwada Tokushukai Hospital, Kishiwada, Osaka, JapanDepartment of Medicine, Baylor College of Medicine, Houston, TX, USA
Interests: Chemotherapy; Image Diagnosis; Nipple-Preserving Surgery; Non-Surgical Ablation; Surgical Technique of Breast Cancer Operation
Special Issue Information

Dear Colleagues,

Breast-conserving treatment has become a standard treatment for stage 1,2 breast cancer for approximately 20 years and has remarkably benefited many patients with small breast cancers. With the advent of sentinel node biopsy, less invasive surgical intervention of breast cancer has further accelerated in breast cancer surgical oncology.  In addition, several therapeutic approaches have been applied to the treatment of breast cancer as follows; 1.neoadjuvant chemotherapy (NAC) has enabled  breast cancer patients with large breast cancers, when responded to NAC, to receive a breast-conserving treatment, leading to favorable cosmetic outcome after operation. 2. oncoplastic techniques, in combination with breast-conserving surgery, have brought about more favorable cosmesis to breast cancer patients . 3. Several types of non-surgical ablation, performed in limited medical facilities, have provided extremely excellent cosmesis to breast cancer patients though they are not standard therapeutic options yet. Breast oncologists, therefore, should take subtype of breast cancer into consideration, in addition to size and localization of the tumor, when to select the therapeutic options. In this special issue, submit your excellent studies to describe various problems concerning how to conserve the breast in breast cancer treatment.

Prof. Dr. Shoji Oura

Guest Editor

Keywords
Breast-Conserving Treatment
Breast Cancer
Neoadjuvant Chemotherapy (NAC)
Oncoplastic Techniques
Non-Surgical Ablation
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 1500 USD. Submitted manuscripts should be well formatted in good English.

Back to top